Piper Sandler Reiterates Overweight Rating on Henry Schein, Inc. (HSIC)

Market Context

Henry Schein, Inc. operates in the Healthcare sector. The stock currently trades at $85.83 with a market capitalization of $9.3B. The stock has gained 20.3% over the past 52 weeks.

Analyst coverage from Piper Sandler provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Henry Schein, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Henry Schein, Inc.

Among the 10 most recent ratings: 4 Buy, 5 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Jul 29, 2026	Piper Sandler	Overweight	N/A
Jul 28, 2026	UBS	Neutral	N/A
Jul 09, 2026	BMO Capital	Market Perform	N/A
Jun 11, 2026	BTIG	Buy	N/A
May 06, 2026	UBS	Neutral	N/A

Related Tools: Analyst Ratings Dashboard | View HSIC Stock Page